Cliff Shin, M.D., Ph.D.

1. Nuclear Medicine Specialist

1. Jones N, Schwartz TM, Bishay S, Robb WH, Sams A, Kogan J, Nable M, Nelson S, Zhao OS, Hohman T, Huang S, Martinez F, Nguyen B, Shin C, Yang M, Westervelt H, Szymkowicz SM, Omary LT, Aqel BA, Dickson R, Lizaola B, Mathur A, Izzy M, Koran MEI. FDG PET of the brain to screen for neurodegenerative disease in older liver transplant candidates. Eur J Nucl Med Mol Imaging. 2025 Jun 5 Epub 2025 June 05
   View PubMed
2. Philip B, Yu DX, Silvis MR, Shin CH, Robinson JP, Robinson GL, Welker AE, Angel SN, Tripp SR, Sonnen JA, VanBrocklin MW, Gibbons RJ, Looper RE, Colman H, Holmen SL. Mutant IDH1 Promotes Glioma Formation In Vivo. Cell Rep. 2018 May 1; 23 (5):1553-1564
   View PubMed
3. Shin CH, Robinson JP, Sonnen JA, Welker AE, Yu DX, VanBrocklin MW, Holmen SL. HBEGF promotes gliomagenesis in the context of Ink4a/Arf and Pten loss. Oncogene. 2017 Aug 10; 36 (32):4610-4618 Epub 2017 Apr 03
   View PubMed
4. Shin CH, Grossmann AH, Holmen SL, Robinson JP. The BRAF kinase domain promotes the development of gliomas in vivo. Genes Cancer. 2015 Jan; 6 (1-2):9-18
   View PubMed
5. Shin CH, Bateman L, Schlaberg R, Bunker AM, Leonard CJ, Hughen RW, Light AR, Light KC, Singh IR. Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome. J Virol. 2011 Jul; 85 (14):7195-202 Epub 2011 May 04
   View PubMed